<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03919747</url>
  </required_header>
  <id_info>
    <org_study_id>20180528/4</org_study_id>
    <nct_id>NCT03919747</nct_id>
  </id_info>
  <brief_title>Oral Contraceptives in Reproductive Age Women</brief_title>
  <official_title>The Awareness About Oral Contraceptives in Reproductive Age Women</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ufuk University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ufuk University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Contraception is an important issue in public health; especially when maternal risks and
      morbidities are considered. There is a need for consciousness about the contraceptive
      choices. The reproductive age women in Turkey may be stubborn or may choose to believe heath
      information. The oral contraceptive drugs are not used because of wrong beliefs. This survey
      study aims to investigate the consciousness and knowledge about the oral contraceptives in 3
      different areas in Turkey.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this study; surveys will be given to reproductive age women admitting to the obstetrics
      and gynecology departments in 3 different cities of Turkey. Survey questions start with the
      education and socioeconomical status of the participants. Mainly the questions include the
      knowledge, ever use about oral contraceptives.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 2, 2019</start_date>
  <completion_date type="Anticipated">July 30, 2019</completion_date>
  <primary_completion_date type="Anticipated">June 2, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Knowledge about oral contraceptives</measure>
    <time_frame>6 months of survey study</time_frame>
    <description>The number of participants who had knowledge about the correct use of OC pills</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Contraindications of OC pills</measure>
    <time_frame>6 months of survey study</time_frame>
    <description>The number of participants who know the contraindications of OC pills /The number of participants who think that OC pills cause infertility</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Knowledge difference in between different regions</measure>
    <time_frame>6 months of survey study</time_frame>
    <description>The number of participants who had knowledge about the correct use of OC pills in different regions</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oral contraceptive use</measure>
    <time_frame>6 months of survey study</time_frame>
    <description>The number of participants that have ever used oral contraceptive pills</description>
  </secondary_outcome>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Contraception Behavior</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Reproductive aged women
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria: The women admitting to the clinics -

        Exclusion Criteria:

        -
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Women are the investigation group</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Recai Pabuccu, Prof.</last_name>
    <role>Study Director</role>
    <affiliation>The Turkish Reproductive Medicine Association</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mine Kiseli, Assoc. Prof.</last_name>
    <phone>+90-532-5080110</phone>
    <email>minekiseli@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Asli Yarci Gursoy</last_name>
    <phone>+90-532-6862822</phone>
    <email>asliyarci@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Karabuk University Hospital</name>
      <address>
        <city>Karabük</city>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sibel Mutlu</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Acıbadem Private Hospital</name>
      <address>
        <city>Kayseri</city>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elif Cinar</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ufuk University Dr Ridvan Ege Hospital</name>
      <address>
        <city>Ankara</city>
        <state>Çankaya</state>
        <zip>06540</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mine Kiseli</last_name>
      <phone>5325080110</phone>
      <email>minekiseli@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>March 16, 2019</study_first_submitted>
  <study_first_submitted_qc>April 17, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 18, 2019</study_first_posted>
  <last_update_submitted>April 17, 2019</last_update_submitted>
  <last_update_submitted_qc>April 17, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 18, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ufuk University</investigator_affiliation>
    <investigator_full_name>Mine Kiseli</investigator_full_name>
    <investigator_title>Assoc. Prof.</investigator_title>
  </responsible_party>
  <keyword>oral contraceptives</keyword>
  <keyword>knowledge</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

